Top Down Review of Healthcare and Biotech Stocks: Growth Opportunities in Biopharma and Genomics….Updates 12/20

Update-3 12/20/25....A recovery week for biotech with XBI up 0.24% at $123.43 after being down to the $119 level,, IBB u p0.46% at $170.20 after being down to $165,76.  Many stocks were up big on Friday' as the WH might be finished with DRUG PRICE negotiations.Some tariff breaks have been given...

Biotech Deals Propel Sector to New 2025 Highs…Update-4…A bullish signal for upcoming week 11/23.

11/24/25...Update-4---11:00a EST-----GREEN SCREEN DAY in early trading with both IBB and XBI at new 2025 highs, laggard ARKG catching up at $29.34 up over 3%. Many 4% movers from our trading list---DNTH new buy, ADPT, ABOS, DNLI, GH, PACB, RYTM,TXG,TEM, and XNCR at a new  2025 high. We will...

Pin It on Pinterest